Product NDC: | 61755-001 |
Proprietary Name: | Arcalyst |
Non Proprietary Name: | rilonacept |
Active Ingredient(s): | 160 mg/2mL & nbsp; rilonacept |
Administration Route(s): | SUBCUTANEOUS |
Dosage Form(s): | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 61755-001 |
Labeler Name: | Regeneron Pharmaceuticals, Inc. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | BLA125249 |
Marketing Category: | BLA |
Start Marketing Date: | 20080227 |
Package NDC: | 61755-001-01 |
Package Description: | 4 VIAL, SINGLE-USE in 1 CARTON (61755-001-01) > 2 mL in 1 VIAL, SINGLE-USE |
NDC Code | 61755-001-01 |
Proprietary Name | Arcalyst |
Package Description | 4 VIAL, SINGLE-USE in 1 CARTON (61755-001-01) > 2 mL in 1 VIAL, SINGLE-USE |
Product NDC | 61755-001 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | rilonacept |
Dosage Form Name | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
Route Name | SUBCUTANEOUS |
Start Marketing Date | 20080227 |
Marketing Category Name | BLA |
Labeler Name | Regeneron Pharmaceuticals, Inc. |
Substance Name | RILONACEPT |
Strength Number | 160 |
Strength Unit | mg/2mL |
Pharmaceutical Classes |